Supreme Court Rules on Prescriber Intent in Opioid Cases
In a ruling on June 27, 2022, the U.S. Supreme Court said prosecutions for cases involving excessive prescribing of opioids must show the prescriber knew they lacked a legitimate medical purpose.
The ruling nominally involves CSA convictions of “pill mill” prescribers in the Tenth and Eleventh circuits, but it carries nationwide implications for criminal and civil cases related to sales and distribution of prescription narcotics for recreational use. Monday’s ruling held that the DOJ “must prove beyond a reasonable doubt that the defendant knew that he or she was acting in an unauthorized manner, or intended to do so,” in order to secure a conviction for improper prescribing.
- For the full article visit: https://www.law360.com/pulse/articles/1483911/prescriber-intent-matters-in-opioid-cases-high-court-rules
- For the full ruling visit: https://www.supremecourt.gov/opinions/21pdf/20-1410_1an2.pdf
Related Posts
Save the Date: PainConnect 2027 & 2028
Published On:
April 2026 President’s Message
Published On:
April Member Focus: Nathaniel Schuster, MD
Published On:
AAPM is dedicated to advancing multidisciplinary pain care, education, advocacy, and research to improve the quality of life for our members and those they treat.
AAPM
Resources
Contact
10440 Little Patuxent Pkwy,
Ste. 300
Columbia, MD 21044
P: (443) 399-1502
©2026 American Academy of Pain Medicine. All Rights Reserved | Privacy Policy | Media Resources
American Academy of Pain Medicine (AAPM) is a nonprofit 501(c)(6) tax-exempt organization.